Valeant Pharmaceuticals International Inc. (VRX, VRX.TO) Thursday agreed to acquire certain assets from Swiss Herbal Remedies Limited, a nutraceutical company that makes scientifically formulated vitamins, minerals and supplements, for less than one times sales.
According to Valeant, total net revenue in 2011 from the acquired assets was about C$28 million.
The transaction is expected to close by June 2012 , subject to certain closing conditions and is expected to be accretive in 2012.
"Swiss Herbal's strong brand awareness in Canada will be a great fit with Valeant's current operations," said Michael Pearson , chairman and chief executive officer.
"Swiss Herbal currently holds a leading position in the Canadian consumer channel and will complement our other product offerings, such as COLD-FX, in this important market segment."
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.